The provisions would also require continued coverage if a patients BMI drops below 35, as long as a doctor certifies that stopping the drug would likely cause the patients BMI to revert above that threshold
Dr Kenneth Custer, Lilly's executive vice president, said: "The 12mg dose delivered a level of weight loss long associated with bariatric surgery." Professor Ania Jastreboff, lead investigator on the trial at Yale School of Medicine, added: "Obesity is a chronic disease, and people living with obesity deserve treatment options that match the complex biology of their neurometabolic disease
As such, patients may experience ancillary anti-aging benefits including improved skin elasticity and the diminishment of fine lines
One bone-in chicken thigh (remove the skin before eating to reduce fat)
Start With a Conversation
In contrast, the pharmacological nanomolar concentrations of GLP-1RAs predominantly activate the cAMP/PKA pathway, potentially explaining their broader therapeutic effects [122]